SCHEMBL3701613

SCHEMBL3701613

O=C(NCc1ccc(OC(F)(F)F)cc1)c1nc2c(C(F)(F)F)cc(-c3ccco3)cn2c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
PTGER4 P35408 2/20 0.41
ADA P00813 1/20 0.40
CYP2C9 P11712 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTR2C P28335 1/20 0.39
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3701552 0.92 ABCB1 (0.45) PKMRXFP1MAPK1ADORA2AADORA1
SCHEMBL3694815 0.92 ALDH1A1 (0.51) PKMRXFP1ALDH1A1MAPK1MEN1
SCHEMBL3702560 0.90 ADORA2A (0.46) PKMRXFP1ALDH1A1MAPK1MEN1
SCHEMBL3696233 0.90 PKM (0.49) PKMRXFP1ALDH1A1MAPK1MEN1
SCHEMBL7495068 0.88 PKM (0.46) PKMRXFP1ALDH1A1MAPK1MEN1
SCHEMBL3688057 0.87 RXFP1 (0.40) PKMRXFP1ALDH1A1MAPK1MEN1
SCHEMBL3697615 0.86 HSD17B13 (0.44) PKMRXFP1MAPK1ADAADORA2A
SCHEMBL7490205 0.86 RXFP1 (0.45) PKMRXFP1ALDH1A1MAPK1MEN1
SCHEMBL3703954 0.86 ADORA3 (0.49) PKMRXFP1ALDH1A1MEN1MAPT
SCHEMBL7490436 0.86 ALDH1A1 (0.48) PKMRXFP1ALDH1A1MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections OAT, HAVCR2, CPS1 PKM 2286/4885RXFP1 4676/4885ALDH1A1 1337/4885
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections OAT, HAVCR2, CPS1 PKM 2286/4885RXFP1 4676/4885ALDH1A1 1337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.